Archives: Agenda

• Improving the sense of security to reduce unnecessary suffering and distress for patients
• Understanding the different types of patients and their individual response behaviours
• Being hyper aware of cultural differences and biases to ensure sensitivity and effective outcomes for all
• Sharing best practice on effective strategies with case studies and examples to help reduce patient drop out rate

• An overview of CAR-T trial trends in Oncology
• How we can apply regulatory, design, logistical and operational lessons learned to the new wave of CAR-T trials in the rare disease space

• Challenges in securing initial funding/additional financing
• Expense associated with drug development
• Loss of new pharmaceutical technologies and cutting-edge compounds
• Impact on patients in need of options

• Focus on the challenges patients face in trials: Learn what the data reveals about barriers to oncology trial participation and the toll of patient dropout.
• Learn how technology (when done right) can make trials easier for oncology patients: Explore solutions like travel support, streamlined patient payments, and eCOA.
• Hear success stories: Find out how recent case studies of eClinical solutions improved the patient and site experience.
• See how a Platform approach creates a smoother experience for patients and sites: Get the latest on the Suvoda-Greenphire merger and its suite of eight unified solutions.

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will be led by a table moderator and will focus on a different challenge within oncology and orphan drug clinical trials. Roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

1. Discussing the increased role of China R&D in developing new products
   Hosted by Sezcan Ozturk, Vice President, Head of Europe, Luzsana Biotechnology
2. AI in clinical operations
   Hosted by Pietro Belligoli, Researcher, Former Roche
3. Running trials in low-cost countries
   Hosted by Martin Neumayer, Head Development Program Support and CRO-Vendor Management, Sandoz
4. What is the best framework of strategies, processes and pathways for pharma and patient organisations to create positive, lasting partnerships?
   Hosted by Dr. Anupoma Haque, EUPATI Fellow, Patient-Centric Public & Digital Health Expert, HTA and Policy Professional, Inclusion & Equity Trainer